Market exclusivity allows innovator companies to recoup sizable investments in the research, development, clinical testing and bringing to market of new products.
Market exclusivity is a key incentive for pharmaceutical, agrichemical and biologics innovator companies to assume the enormous risks associated with their investments in R&D and marketing: once a new product comes to market, meaningful profits are possible only through at least some period of exclusive rights for the product.
Around the world, innovator companies use various mechanisms to achieve market exclusivity for any new product. The most pervasive mechanism is patent protection, which under the World Trade Organization Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement ensures patent owners exclusive rights “to prevent third parties not having the owner’s consent from the acts of: making, using, offering for sale, selling, or importing” the patented product for the duration of the patent.
Other mechanisms are available in countries such as the US and in the EU, including patent term extension, data exclusivity and patent linkage.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
To request a FREE 2-week trial subscription, use the same link but select the 'trial' option in the dropdown box. NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at email@example.com
Pharmaceutical, biotech, patent, market exclusivity